Guideline Publication Schedule
Published: October 08, 2024
Topics listed below include AHA/ACC joint cardiovascular publications and AHA/ASA stroke publications. The publication schedule is shown by quarter, using a January–December calendar.
Guidelines
| AHA/ACC Clinical Practice Guidelines | Publication |
|---|---|
| Hypertrophic Cardiomyopathy | 2025 – Reaffirmed* |
| Adults with Congenital Heart Disease | 2025 – Quarter 4 |
| Acute Pulmonary Embolism | 2026 – Quarter 1 |
| Cholesterol | 2026 – Quarter 1 |
| Cardiovascular-Kidney-Metabolic Syndrome | 2026 – Quarter 2 |
| Primary Prevention of Cardiovascular Disease | 2026 – Quarter 4 |
| Valvular Heart Disease | 2026 – Quarter 4 |
| Pulmonary Hypertension | 2027 – Quarter 1 |
| AHA/ASA Clinical Practice Guidelines | Publication |
|---|---|
| Acute Ischemic Stroke | 2026 – Quarter 1 |
| Stroke Rehabilitation and Recovery | 2026 – Quarter 3 |
Performance Measures
| Joint AHA/ACC Performance Measures | Publication |
|---|---|
| Peripheral Artery Disease | 2026 – Quarter 1 |
| Atrial Fibrillation | 2026 – Quarter 4 |
*Reaffirmation is defined as having reviewed the literature over a specified period of time to assess whether updates to the recommendations or content of a clinical guideline are warranted. If, upon review, no substantive changes are deemed necessary, a formal decision to reaffirm the guideline is made.
This 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline has been reviewed and determined to be current as of May 2025.